Biopharmaceutical tubing market seen reaching $8.12 billion by 2030

The biopharmaceutical tubing market is projected to grow from $5.32 billion in 2026 to $8.12 billion by 2030, according to The Business Research Company. Demand is being lifted by biologics, cell and gene therapies, single-use systems and personalized medicine, with North America leading and Asia-Pacific growing fastest.

Why it matters: - Biopharmaceutical tubing is a critical input for sterile, precise fluid transfer in drug manufacturing and administration. - Growth in the market tracks broader expansion in biologics, personalized medicine and advanced bioprocessing. - The report’s forecast signals rising demand for high-purity tubing across pharmaceuticals, medical devices and research settings.

What happened: - The Business Research Company released its "Biopharmaceutical Tubing Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035." - The market was valued at $4.79 billion in 2025 and is projected to reach $5.32 billion in 2026. - The market is forecast to climb to $8.12 billion by 2030, implying an 11.1% compound annual growth rate. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company published a free sample of the report and the full market report.

The details: - Historical growth was supported by expanded biopharmaceutical manufacturing capacity. - Greater use of standardized sterile components also supported demand. - Early adoption of silicone and PVC tubing in drug production helped build the market. - Contract manufacturing and fill-finish operations added to demand. - Regulatory focus on material biocompatibility and purity strengthened the market backdrop. - Future growth is tied to a growing pipeline of biologics and cell and gene therapy products. - Single-use and disposable processing systems are expected to support additional demand. - High-performance TPE and polyolefin tubing are gaining importance. - Automated production and closed-system workflows are expanding. - Investments in advanced bioprocessing technologies and aseptic transfer methods are reinforcing the outlook. - Key trends include higher use of high-purity, biocompatible tubing and sterile transfer systems. - Precision fluid handling requirements are rising in manufacturing and fill-finish processes. - Applications are expanding in pharmaceuticals, medical devices and R&D environments.

Between the lines: - Personalized medicine is becoming a stronger demand driver because customized therapies require precise and sterile fluid handling. - The market’s growth rate suggests tubing is becoming more strategically important as manufacturing shifts toward cleaner, more automated and more disposable systems. - The reported regional split points to an established North American base and a faster expansion runway in Asia-Pacific. - In February 2024, the Personalized Medicine Coalition reported that the FDA approved 26 new personalized therapies in 2023, up from 18 in 2022.

What's next: - The market is expected to keep expanding through 2030 as biologics and gene and cell therapies move through the pipeline. - Demand should remain strong for sterile, biocompatible and high-performance tubing materials. - The Business Research Company is also promoting expanded 2026 report features, including market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards and market hotspot infographics.

The bottom line: - Biopharmaceutical tubing is shifting from a niche component to a growth market tied directly to the next generation of drug manufacturing.